The Niva Bupa Health Insurance IPO is set to open for subscription on November 7, 2024, and will close on November 11, 2024. With a target to raise ₹2,200 crore, the IPO comprises a fresh issue of ₹800 crore and an offer for sale (OFS) of ₹1,400 crore. The Niva Bupa IPO price band is set between ₹70 and ₹74 per share, and investors must purchase a minimum of 200 shares for an investment of ₹14,000. With strong financial performance, Niva Bupa’s Gross Direct Premium Income (GDPI) reached ₹5,494 crore in FY2024, showing a CAGR of 41.37% over recent years. Those interested in developing a deeper understanding of IPO analysis can learn from GRM IIT for both free and paid content, including on our YouTube channel and website.
Niva Bupa Health Insurance IPO GMP and Key Dates
Tracking the Niva Bupa Health Insurance IPO GMP is essential for those monitoring market trends and demand. Here are the key dates for the Niva Bupa IPO:
- IPO Open Date: November 7, 2024
- IPO Close Date: November 11, 2024
- Allotment Date: Expected on November 12, 2024
- Listing Date: Tentatively scheduled for November 14, 2024
The Niva Bupa Health Insurance IPO GMP will help investors gauge the anticipated market response and potential gains from listing. Observing Niva Bupa IPO GMP figures closer to the listing date offers valuable insights into market sentiment.
Niva Bupa Health Insurance IPO Price Band and Minimum Investment
The Niva Bupa IPO price band is set between ₹70 and ₹74 per share, providing an accessible entry point into the healthcare insurance sector. To invest, a minimum of 200 shares is required, making the initial investment ₹14,000. This price range positions Niva Bupa Health Insurance IPO price as competitive among other industry leaders, with robust growth potential.
Niva Bupa IPO Shareholder Quota Allocation
Understanding the Niva Bupa IPO shareholder quota is important for planning investments. The allocation breakdown is as follows:
- Qualified Institutional Buyers (QIBs): 75%
- Non-Institutional Investors (NIIs): 15%
- Retail Investors: 10%
The Niva Bupa IPO shareholder quota distribution allows retail and institutional investors to assess the demand and chances of allotment based on their investor category.
Financial Performance and Market Position
The Niva Bupa Health Insurance IPO review highlights the company’s impressive financial growth:
- Gross Direct Premium Income (GDPI): ₹5,494 crore in FY2024
- CAGR in GDPI (FY22-FY24): 41.37%
- Net Profit in FY2024: ₹81.85 crore, up from ₹12.54 crore in FY2023
This strong performance places Niva Bupa Health Insurance IPO price within a company with significant market share. In the last fiscal year, the Niva Bupa health insurance business had over 14 million active lives insured across 22 states and 4 union territories in India. This achievement strengthens its position as a major player in the health insurance sector.
Niva Bupa Health Insurance IPO GMP and Unlisted Share Price
Keeping an eye on the Niva Bupa Health Insurance IPO GMP is essential to understand its valuation on the grey market. While the exact Niva Bupa IPO GMP is not yet confirmed, tracking it closer to the Niva Bupa IPO date will give insights into investor sentiment. Additionally, updates on the Niva Bupa unlisted share price before the listing date can help investors gauge market enthusiasm for this IPO.
Niva Bupa IPO Price Band and Market Comparisons
In terms of the Niva Bupa Health Insurance IPO price band, this IPO provides an attractive entry into the fast-growing health insurance market. Competing with other major health insurers, Niva Bupa leverages advanced technologies like machine learning for fraud detection and streamlined operations, reinforcing its market standing.
Acme Solar IPO GMP: Why It Matters
Comparing the Acme Solar IPO GMP with the Niva Bupa Health Insurance IPO GMP can offer further context on how the market values companies in the healthcare and energy sectors. While the two industries are distinct, understanding Acme Solar IPO GMP trends can provide additional perspective on the broader IPO landscape and investor expectations.
Final Thoughts on the Niva Bupa Health Insurance IPO
The Niva Bupa Health Insurance IPO stands out as a strong investment opportunity, backed by an impressive CAGR of 41.37% in GDPI and a surge in net profit to ₹81.85 crore. For those interested in learning more about investment analysis, GRM IIT offers valuable resources and training. Visit our YouTube channel for free insights or our website for comprehensive courses.
Ready to invest? Start by creating your Demat account with GRM Bulls for full financial services and assistance.
